Met Life Investment Management, LLC Vera Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $14.7 Billion
- Q1 2024
A detailed history of Met Life Investment Management, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 20,653 shares of VERA stock, worth $747,225. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,653Holding current value
$747,225% of portfolio
0.01%Shares
7 transactions
Others Institutions Holding VERA
# of Institutions
173Shares Held
52.7MCall Options Held
117KPut Options Held
290K-
Avoro Capital Advisors LLC New York, NY5.27MShares$190 Million2.74% of portfolio
-
Black Rock Inc. New York, NY3.32MShares$120 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.17MShares$115 Million11.79% of portfolio
-
Abingworth LLP London, X02.96MShares$107 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$101 Million7.01% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $978M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...